A remarkable advancement in stem cell therapy has opened new possibilities for the treatment of type 1 diabetes, a chronic condition that has long been seen as incurable. Scientists in China have ...

Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%.

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Additionally, the company is progressing with its diabetes gene therapy program ... as well as developing gene therapies for Type 1 and Type 2 diabetes in collaboration with the University ...

While the company is prioritizing RJVA-001 and a lead program in obesity, it's pausing some R&D efforts and laying off 17 percent of its workforce.

People with type 1 diabetes need insulin therapy, either through injections ... Monogenic diabetes is a rare type caused by a change in a single gene. People with monogenic forms sometimes present ...

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...

Gene therapy partially restores visual processing in the geniculostriate pathway of patients with Leber congenital amaurosis type 2 while maintaining compensatory activity in the retinotectal pathway.

Genprex's diabetes gene therapy approach is comprised of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes ...